Carrier-dependent specificity of antibodies to a conserved peptide determinant of gp120.

[1]  Y. Nishiyama,et al.  Synthesis of a Covalently Reactive Antigen Analog Derived from a Conserved Sequence of HIV-1 gp120 , 2001 .

[2]  J. Sodroski,et al.  Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody , 1998, Nature.

[3]  I. Rubinstein,et al.  Stabilization of vasoactive intestinal peptide by lipids. , 1998, The Journal of pharmacology and experimental therapeutics.

[4]  A. Trkola,et al.  HIV type 1 coreceptors, neutralization serotypes, and vaccine development. , 1997, AIDS research and human retroviruses.

[5]  C. Montesano,et al.  Epitope specificity of anti-HIV antibodies in human and murine autoimmune diseases. , 1996, AIDS research and human retroviruses.

[6]  J. O'dell,et al.  Unexpected presence of polyreactive catalytic antibodies in IgG from unimmunized donors and decreased levels in rheumatoid arthritis. , 1995, Journal of immunology.

[7]  H. Kiyono,et al.  Neutralization of HIV-1 by secretory IgA induced by oral immunization with a new macromolecular multicomponent peptide vaccine candidate , 1995, Nature Medicine.

[8]  J. Berzofsky,et al.  Binding of glycoprotein 120 and peptides from the HIV-1 envelope by autoantibodies in mice with experimentally induced systemic lupus erythematosus and in patients with the disease. , 1994, AIDS Research and Human Retroviruses.

[9]  J. Berzofsky,et al.  Construction of an HIV-1 peptide vaccine containing a multideterminant helper peptide linked to a V3 loop peptide 18 inducing strong neutralizing antibody responses in mice of multiple MHC haplotypes after two immunizations. , 1993, Journal of immunology.

[10]  I. Wilson,et al.  Structural evidence for induced fit as a mechanism for antibody-antigen recognition. , 1994, Science.

[11]  J. Sodroski,et al.  Discontinuous, conserved neutralization epitopes overlapping the CD4-binding region of human immunodeficiency virus type 1 gp120 envelope glycoprotein , 1992, Journal of virology.

[12]  W. Williams,et al.  Synthetic peptides from a conserved region of gp120 induce broadly reactive anti-HIV responses. , 1992, Immunology.

[13]  L. Montagnier,et al.  Specificity of anti-peptide antibodies elicited against synthetic peptides mimicking conserved regions of HIV1 envelope glycoprotein. , 1991, Research in virology.

[14]  J. Sodroski,et al.  Identification of individual human immunodeficiency virus type 1 gp120 amino acids important for CD4 receptor binding , 1990, Journal of virology.

[15]  L. Eckler,et al.  Epitopes recognized by the neutralizing antibodies of an HIV-1-infected individual. , 1990, Journal of immunology.

[16]  J. Sodroski,et al.  Effects on CD4 binding of anti-peptide sera to the fourth and fifth conserved domains of HIV-1 gp120. , 1990, Journal of acquired immune deficiency syndromes.

[17]  Antonio Lanzavecchia,et al.  Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells , 1989, European journal of immunology.

[18]  T. H. Lee,et al.  Generation and characterization of monoclonal antibodies to the putative CD4-binding domain of human immunodeficiency virus type 1 gp120 , 1989, Journal of virology.

[19]  Smith Gd,et al.  X-ray diffraction studies of enkephalins and opiates. , 1988 .

[20]  T. Dyrberg,et al.  Peptides as antigens. Importance of orientation , 1986, The Journal of experimental medicine.

[21]  K. Fujiwara,et al.  Novel preparation method of immunogen for hydrophobic hapten, enzyme immunoassay for daunomycin and adriamycin. , 1981, Journal of immunological methods.

[22]  M. Sela,et al.  ANTIBODY RESPONSE OF INBRED MOUSE STRAINS TO ORDERED TETRAPEPTIDES OF TYROSINE AND GLUTAMIC ACID ATTACHED TO MULTICHAIN POLYALANINE OR POLYPROLINE , 1974, The Journal of experimental medicine.

[23]  G. Ellman,et al.  Tissue sulfhydryl groups. , 1959, Archives of biochemistry and biophysics.